loader image
Wednesday, January 7, 2026
75.4 F
McAllen
- Advertisement -

Does ADHD Medication Help with Cognitive Function? Study Offers Insight

Translate to Spanish or other 102 languages!

A new study found that stimulant and non-stimulant medications prescribed for ADHD improve long-term cognitive function in people with the condition. Image for illustration purposes
A new study found that stimulant and non-stimulant medications prescribed for ADHD improve long-term cognitive function in people with the condition. Image for illustration purposes
- Advertisement -
  • Stimulant and non-stimulant medications prescribed for ADHD improve cognitive function, according to a new study.
  • The researchers examined the long-term effects of both types of drugs, and concluded these medications offered similar — but not identical — cognitive benefits.
  • ADHD medications affect the uptake of dopamine and noradrenaline, two brain chemicals that are typically lower in people with this condition.

Common medicines for treating attention-deficit hyperactivity disorder (ADHD) promote cognitive function, according to new research.

Follow the link below to read the full story at Medical News Today:

https://www.medicalnewstoday.com/articles/adhd-medications-improve-long-term-cognitive-function

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Dry January Participation Linked to Noticeable Health Improvements

Mega Doctor News Medical News Today In 2013, Alcohol Change UK started the “Dry...

The Importance of Giving the Gift of Life

January is National Blood Donor Month, and According to the Red Cross, every two seconds someone in the United States needs blood. 

No-Cost COVID-19 Testing Ends January 31st

The Hidalgo County Health & Human Services Department announces that no-cost COVID-19 testing at the Hidalgo County Public Health Laboratory will conclude on January 31, 2026.

MD Anderson Partners with SOPHiA GENETICS to Accelerate Innovation in AI Precision Oncology

The University of Texas MD Anderson Cancer Center and SOPHiA GENETICS today announced a strategic collaboration that unites SOPHiA GENETICS’ AI-powered analytics with MD Anderson’s clinical and scientific expertise to accelerate data-driven cancer care through new tools that can accurately analyze, interpret and translate diagnostic results into clinical practice.
- Advertisement -
×